Nasal vestibule brachytherapy shows improving dose homogeneity despite increasing implant complexity
Across 85 nasal vestibule carcinoma patients, HDR brachytherapy evolved toward larger targets and more catheters while reducing dose heterogeneity.
Across 85 nasal vestibule carcinoma patients, HDR brachytherapy evolved toward larger targets and more catheters while reducing dose heterogeneity.
In 16 sinonasal cancer planning cases, LET optimization reduced chiasm LET from 3.1 to 2.3 keV/μm while maintaining target coverage.
Regional lymph node irradiation was linked to attenuated local cytokine shifts and nodal damage and cell-death signatures after sinonasal stereotactic radiotherapy.